These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8073823)

  • 41. Evidence for CD8+ cell increase in long-term PUVA-treated psoriatic patients after PUVA discontinuation.
    Borroni G; Zaccone C; Vignati G; Fietta A; Merlini C; Rabbiosi G
    Dermatology; 1992; 185(1):69-71. PubMed ID: 1638076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psoriatic microangiopathy modifications induced by PUVA and etretinate therapy. A nail-fold capillary microscopic study.
    Trevisan G; Magaton Rizzi G; Dal Canton M
    Acta Derm Venereol Suppl (Stockh); 1989; 146():53-6; discussion 56-7. PubMed ID: 2609884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
    Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
    Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed onset of bullous pemphigoid after PUVA and sunlight treatment of psoriasis.
    Albergo RP; Gilgor RS
    Cutis; 1982 Nov; 30(5):621-4. PubMed ID: 6756797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of PUVA treatment on the substructure of nevocellular nevi in psoriatic patients.
    Lagerholm B; Frithz A
    Acta Derm Venereol; 1982; 62(1):7-14. PubMed ID: 6175143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA.
    Gritiyarangsan P; Sindhavananda J; Rungrairatanaroj P; Kullavanijaya P
    Photodermatol Photoimmunol Photomed; 1995 Aug; 11(4):174-7. PubMed ID: 8850252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis.
    El-Domyati M; Moftah NH; Nasif GA; Abdel-Wahab HM; Barakat MT; Abdel-Aziz RT
    Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):18-26. PubMed ID: 23281693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A.
    Wolf P; Seidl H; Bäck B; Binder B; Höfler G; Quehenberger F; Hoffmann C; Kerl H; Stark S; Pfister HJ; Fuchs PG
    Arch Dermatol; 2004 Mar; 140(3):317-24. PubMed ID: 15023775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [PUVA--therapy with low UV-A dose].
    Hesse G; Wichmann-Hesse AC; Bercher M
    Z Hautkr; 1987 Jun; 62(12):927-30, 935-6. PubMed ID: 3617861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Objective assessment of photoageing effects using high-frequency ultrasound in PUVA-treated psoriasis patients.
    Sator PG; Schmidt JB; Hönigsmann H
    Br J Dermatol; 2002 Aug; 147(2):291-8. PubMed ID: 12174102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphopenia and decrease in the total number of circulating CD3+ and CD4+ T cells during 'long-term' PUVA treatment for psoriasis.
    Borroni G; Zaccone C; Vignati G; Fietta A; Gatti M; Brazzelli V; Rabbiosi G
    Dermatologica; 1991; 183(1):10-4. PubMed ID: 1837524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Psoralen ultraviolet A (PUVA) photochemotherapy plus topical corticosteroids with PUVA plus bland emollients in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Ayub Med Coll Abbottabad; 2005; 17(1):34-6. PubMed ID: 15929524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Actinic degeneration in association with long-term use of PUVA.
    Stern RS; Parrish JA; Fitzpatrick TB; Bleich HL
    J Invest Dermatol; 1985 Feb; 84(2):135-8. PubMed ID: 3968447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Side-effects of psoralen photochemotherapy (PUVA).
    Wolff K
    Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
    Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
    Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skin phototypes in psoriatic patients treated by the PUVA method.
    Nozicková M
    Acta Univ Carol Med (Praha); 1986; 32(3-4):225-8. PubMed ID: 3434479
    [No Abstract]   [Full Text] [Related]  

  • 59. [Chemotaxis activity of neutrophils and monocytes in patients with psoriasis vulgaris in relation to PUVA therapy].
    Poljacki M; Jovanović M; Budakov M; Duran V; Subotić M
    Med Pregl; 1995; 48(7-8):217-21. PubMed ID: 8524193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of PUVA and mechlorethamine treatment of psoriatic patients on epidermal Langerhans' cells.
    Torinuki W; Mauduit G; Haftek M; Thivolet J
    Acta Derm Venereol; 1987; 67(6):532-5. PubMed ID: 2451383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.